89bio Inc. (ETNB) NASDAQ

$2.96 0.09 (3.14%)

Market Cap: $60.24M

As of 05/18/22 04:00 PM EDT. Market closed.

(ETNB)

89bio Inc. (ETNB) NASDAQ

$2.96 0.09 (3.14%)

Market Cap: $60.24M

As of 05/18/22 04:00 PM EDT. Market closed.

89bio is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases. The company's lead product candidate, BIO89-100, is a specifically engineered glycoPEGylated analog of FGF21. BIO89-100 is being developed for the treatment of nonalcoholic steatohepatitis (NASH) and severe ... read more

89bio is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases. The company's lead product candidate, BIO89-100, is a specifically engineered glycoPEGylated analog of FGF21. BIO89-100 is being developed for the treatment of nonalcoholic steatohepatitis (NASH) and severe hypertriglyceridemia (SHTG). 89bio is headquartered in San Francisco with operations in Herzliya, Israel. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
URL
Address
.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Full Time Employees
27
URL
Address
.
PRICE CHART
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
KEY STATS
Open
$0
Previous Close
$2.87
Days Range
$2.82 - $3.18
52 week range
$2 - $23.07
Volume
0
Avg. Volume (30 days)
296,202
Market Cap
$60.24M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
20,351,384
Open
$0
Previous Close
$2.87
Days Range
$2.82 - $3.18
52 week range
$2 - $23.07
Volume
0
Avg. Volume (30 days)
296,202
Market Cap
$60.24M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
20,351,384

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR 89BIO INC
Owner Relationship Date Transaction Cost # Shares Value($) Total Shares Form 4
Mansbach Harry H Chief Medical Officer Feb 05, 2022 Option Exercise $5.23 1,363 7,128 31,137 Apr 13, 2022, 04:05 PM
Martins Ryan Chief Financial Officer Feb 05, 2022 Option Exercise $5.23 1,022 5,345 22,478 Apr 13, 2022, 04:05 PM
PALEKAR ROHAN Chief Executive Officer Feb 05, 2022 Option Exercise $5.23 4,088 21,380 95,957 Apr 13, 2022, 04:05 PM
Le-Nguyen Quoc See Remarks Feb 05, 2022 Option Exercise $5.23 1,363 7,128 31,137 Apr 13, 2022, 04:05 PM
Waisbourd Ram See Remarks Feb 01, 2022 Option Exercise $1.93 7,000 13,510 7,000 Feb 03, 2022, 04:30 PM
Waisbourd Ram See Remarks Feb 01, 2022 Sale $5.70 7,000 39,900 0 Feb 03, 2022, 04:30 PM
PALEKAR ROHAN Chief Executive Officer Jan 28, 2022 Buy $6.14 2,500 15,350 45,845 Jan 31, 2022, 04:30 PM
PALEKAR ROHAN Chief Executive Officer Jan 27, 2022 Buy $7.50 5,000 37,500 43,345 Jan 31, 2022, 04:30 PM
ORBIMED ADVISORS LLC 10% Owner Jan 26, 2022 Sale $8.38 21,482 180,019 1,829,436 Jan 27, 2022, 05:22 PM
ORBIMED ADVISORS LLC 10% Owner Jan 25, 2022 Sale $8.40 49,091 412,364 1,840,176 Jan 27, 2022, 05:22 PM
Waisbourd Ram See Remarks Dec 16, 2021 Option Exercise $1.93 7,000 13,510 7,000 Dec 20, 2021, 04:30 PM
Waisbourd Ram See Remarks Dec 16, 2021 Sale $11.48 7,000 80,360 0 Dec 20, 2021, 04:30 PM
Waisbourd Ram See Remarks Nov 16, 2021 Option Exercise $1.93 7,000 13,510 7,000 Nov 18, 2021, 06:37 PM
Waisbourd Ram See Remarks Nov 16, 2021 Sale $16.49 7,000 115,430 0 Nov 18, 2021, 06:37 PM
Waisbourd Ram See Remarks Oct 18, 2021 Option Exercise $1.93 7,000 13,510 7,000 Oct 20, 2021, 04:30 PM
Waisbourd Ram See Remarks Oct 18, 2021 Sale $17.49 7,000 122,430 0 Oct 20, 2021, 04:30 PM
Waisbourd Ram See Remarks Sep 16, 2021 Option Exercise $1.93 7,000 13,510 7,000 Sep 20, 2021, 04:32 PM
Waisbourd Ram See Remarks Sep 16, 2021 Sale $19.46 7,000 136,220 0 Sep 20, 2021, 04:32 PM
Waisbourd Ram See Remarks Aug 16, 2021 Option Exercise $1.93 7,000 13,510 7,000 Aug 18, 2021, 04:10 PM
Waisbourd Ram See Remarks Aug 16, 2021 Sale $18.28 7,000 127,960 0 Aug 18, 2021, 04:10 PM
Waisbourd Ram See Remarks Jul 16, 2021 Option Exercise $1.93 7,000 13,510 7,000 Jul 19, 2021, 04:05 PM
Waisbourd Ram See Remarks Jul 16, 2021 Sale $16.80 7,000 117,600 0 Jul 19, 2021, 04:05 PM
PALEKAR ROHAN Chief Executive Officer Jul 08, 2021 Buy $16.25 2,000 32,500 37,000 Jul 08, 2021, 04:05 PM
PALEKAR ROHAN Chief Executive Officer Jul 07, 2021 Buy $17.07 5,000 85,350 35,000 Jul 08, 2021, 04:05 PM
RA CAPITAL MANAGEMENT, L.P. Director Jun 02, 2021 Buy $18.77 22,138 415,530 4,965,769 Jun 04, 2021, 04:31 PM
Grunberg Gregory Director Apr 21, 2021 Sale $27.60 850 23,460 0 Apr 23, 2021, 05:27 PM
Waisbourd Ram See Remarks Mar 16, 2021 Option Exercise $1.93 7,000 13,510 7,000 Mar 17, 2021, 04:30 PM
Waisbourd Ram See Remarks Mar 16, 2021 Sale $24.20 7,000 169,400 0 Mar 17, 2021, 04:30 PM
Hayden Michael R Director Feb 23, 2021 Option Exercise $2.13 80,904 172,236 80,904 Feb 25, 2021, 05:01 PM
Waisbourd Ram See Remarks Feb 16, 2021 Option Exercise $1.93 7,000 13,510 7,000 Feb 17, 2021, 04:22 PM
Waisbourd Ram See Remarks Feb 16, 2021 Sale $23.39 7,000 163,730 0 Feb 17, 2021, 04:22 PM
Waisbourd Ram See Remarks Jan 19, 2021 Option Exercise $1.93 7,000 13,510 7,000 Jan 20, 2021, 04:30 PM
Waisbourd Ram See Remarks Jan 19, 2021 Sale $21.16 7,000 148,120 0 Jan 20, 2021, 04:30 PM
Waisbourd Ram See Remarks Dec 16, 2020 Option Exercise $1.93 7,000 13,510 7,000 Dec 18, 2020, 05:00 PM
Waisbourd Ram See Remarks Dec 16, 2020 Sale $27.04 7,000 189,280 0 Dec 18, 2020, 05:00 PM
Le-Nguyen Quoc See Remarks Nov 16, 2020 Option Exercise $3.11 4,548 14,144 4,548 Nov 18, 2020, 04:00 PM
Le-Nguyen Quoc See Remarks Nov 16, 2020 Sale $28.11 4,548 127,844 0 Nov 18, 2020, 04:00 PM
Waisbourd Ram COO and Chief Business Officer Nov 16, 2020 Option Exercise $1.93 7,000 13,510 7,000 Nov 18, 2020, 04:00 PM
Waisbourd Ram COO and Chief Business Officer Nov 16, 2020 Sale $27.39 7,000 191,730 0 Nov 18, 2020, 04:00 PM
ORBIMED ADVISORS LLC Director Sep 21, 2020 Sale $28.00 275,000 7,700,000 1,864,721 Sep 23, 2020, 05:09 PM
Naschitz Anat Director Sep 21, 2020 Sale $28.00 275,000 7,700,000 1,864,721 Sep 23, 2020, 05:04 PM
RA CAPITAL MANAGEMENT, L.P. Director Sep 17, 2020 Buy $28.00 1,300,000 36,400,000 4,736,214 Sep 21, 2020, 04:30 PM
Longitude Capital Partners III, LLC 10% Owner Jul 10, 2020 Buy $27.50 109,090 2,999,975 2,600,877 Jul 14, 2020, 08:11 PM
Grunberg Gregory Director Jul 10, 2020 Buy $27.50 109,090 2,999,975 2,600,877 Jul 14, 2020, 08:08 PM
RA CAPITAL MANAGEMENT, L.P. Director Jul 08, 2020 Buy $27.50 275,000 7,562,500 3,436,214 Jul 10, 2020, 04:32 PM
Kariv Tomer Director Nov 11, 2019 Buy $16.00 250,000 4,000,000 250,000 Nov 13, 2019, 07:10 PM
Naschitz Anat Director Nov 11, 2019 Buy $16.00 837,500 13,400,000 724,363 Nov 13, 2019, 07:07 PM
RA CAPITAL MANAGEMENT, L.P. Director Nov 11, 2019 Buy $16.00 1,500,000 24,000,000 1,500,000 Nov 13, 2019, 07:06 PM
Grunberg Gregory Director Nov 11, 2019 Buy $16.00 575,000 9,200,000 575,000 Nov 13, 2019, 07:04 PM
Hayden Michael R Director Nov 11, 2019 Buy $16.00 18,750 300,000 18,750 Nov 13, 2019, 07:02 PM
Longitude Capital Partners III, LLC 10% Owner Nov 11, 2019 Buy $16.00 575,000 9,200,000 575,000 Nov 13, 2019, 07:02 PM
ORBIMED ADVISORS LLC Director Nov 11, 2019 Buy $16.00 837,500 13,400,000 724,363 Nov 13, 2019, 07:00 PM
Load More Insider Transactions
Buy Sale Option Exercise
Owner Relationship Date Value($)
Mansbach Harry H Chief Medical Officer 02/05/2022 7,128
Martins Ryan Chief Financial Officer 02/05/2022 5,345
PALEKAR ROHAN Chief Executive Officer 02/05/2022 21,380
Le-Nguyen Quoc See Remarks 02/05/2022 7,128
Waisbourd Ram See Remarks 02/01/2022 13,510
Waisbourd Ram See Remarks 02/01/2022 39,900
PALEKAR ROHAN Chief Executive Officer 01/28/2022 15,350
PALEKAR ROHAN Chief Executive Officer 01/27/2022 37,500
ORBIMED ADVISORS LLC 10% Owner 01/26/2022 180,019
ORBIMED ADVISORS LLC 10% Owner 01/25/2022 412,364
Waisbourd Ram See Remarks 12/16/2021 13,510
Waisbourd Ram See Remarks 12/16/2021 80,360
Waisbourd Ram See Remarks 11/16/2021 13,510
Waisbourd Ram See Remarks 11/16/2021 115,430
Waisbourd Ram See Remarks 10/18/2021 13,510
Waisbourd Ram See Remarks 10/18/2021 122,430
Waisbourd Ram See Remarks 09/16/2021 13,510
Waisbourd Ram See Remarks 09/16/2021 136,220
Waisbourd Ram See Remarks 08/16/2021 13,510
Waisbourd Ram See Remarks 08/16/2021 127,960
Waisbourd Ram See Remarks 07/16/2021 13,510
Waisbourd Ram See Remarks 07/16/2021 117,600
PALEKAR ROHAN Chief Executive Officer 07/08/2021 32,500
PALEKAR ROHAN Chief Executive Officer 07/07/2021 85,350
RA CAPITAL MANAGEMENT, L.P. Director 06/02/2021 415,530
Grunberg Gregory Director 04/21/2021 23,460
Waisbourd Ram See Remarks 03/16/2021 13,510
Waisbourd Ram See Remarks 03/16/2021 169,400
Hayden Michael R Director 02/23/2021 172,236
Waisbourd Ram See Remarks 02/16/2021 13,510
Waisbourd Ram See Remarks 02/16/2021 163,730
Waisbourd Ram See Remarks 01/19/2021 13,510
Waisbourd Ram See Remarks 01/19/2021 148,120
Waisbourd Ram See Remarks 12/16/2020 13,510
Waisbourd Ram See Remarks 12/16/2020 189,280
Le-Nguyen Quoc See Remarks 11/16/2020 14,144
Le-Nguyen Quoc See Remarks 11/16/2020 127,844
Waisbourd Ram COO and Chief Business Officer 11/16/2020 13,510
Waisbourd Ram COO and Chief Business Officer 11/16/2020 191,730
ORBIMED ADVISORS LLC Director 09/21/2020 7,700,000
Naschitz Anat Director 09/21/2020 7,700,000
RA CAPITAL MANAGEMENT, L.P. Director 09/17/2020 36,400,000
Longitude Capital Partners III, LLC 10% Owner 07/10/2020 2,999,975
Grunberg Gregory Director 07/10/2020 2,999,975
RA CAPITAL MANAGEMENT, L.P. Director 07/08/2020 7,562,500
Kariv Tomer Director 11/11/2019 4,000,000
Naschitz Anat Director 11/11/2019 13,400,000
RA CAPITAL MANAGEMENT, L.P. Director 11/11/2019 24,000,000
Grunberg Gregory Director 11/11/2019 9,200,000
Hayden Michael R Director 11/11/2019 300,000
Longitude Capital Partners III, LLC 10% Owner 11/11/2019 9,200,000
ORBIMED ADVISORS LLC Director 11/11/2019 13,400,000
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING
STOCK BUYBACKS
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2021
09/30/2021
0.27%
1Q
12/31/2021
06/30/2021
0.40%
2Q
12/31/2021
03/31/2021
0.44%
3Q
12/31/2021
12/31/2020
24.93%
4Q
12/31/2021
09/30/2020
35.72%
5Q
12/31/2021
06/30/2020
45.71%
6Q
12/31/2021
03/31/2020
45.75%
7Q
Load More

Period of Report: 12/31/2021

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2021
0.27%
1Q
06/30/2021
0.40%
2Q
03/31/2021
0.44%
3Q
12/31/2020
24.93%
4Q
09/30/2020
35.72%
5Q
06/30/2020
45.71%
6Q
03/31/2020
45.75%
7Q
Load More